• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4-disubstituted thiazoles

Introduction to Methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine (CAS No. 642929-37-1)

Methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine, a compound with the chemical identifier CAS No. 642929-37-1, represents a significant area of interest in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the class of thiazole derivatives, which are well-documented for their diverse biological activities and potential therapeutic applications. The structural motif of this molecule, featuring a thiazole ring fused with an amine functionalities, makes it a compelling candidate for further investigation in drug discovery and development.

The< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine molecule exhibits a unique combination of chemical properties that make it suitable for various synthetic pathways. The presence of both methyl and ethyl groups attached to the thiazole ring introduces steric and electronic effects that can modulate its reactivity and binding affinity to biological targets. This characteristic has garnered attention from researchers exploring novel pharmacophores for treating a range of diseases.

In recent years, there has been a surge in research focused on thiazole derivatives due to their broad spectrum of biological activities. Thiazole-based compounds have shown promise in various therapeutic areas, including antimicrobial, anti-inflammatory, anticancer, and antiviral applications. The< strong>thiazole ring itself is known for its stability and ability to interact with biological systems through multiple mechanisms. By incorporating substituents such as methyl and ethyl groups, chemists can fine-tune the pharmacological properties of these molecules to enhance their efficacy and selectivity.

The< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine compound has been studied in the context of developing new drugs that target specific enzymes or receptors involved in disease pathways. For instance, modifications to the thiazole ring can influence its ability to inhibit or activate certain enzymes, which is crucial for drug design. The amine functionality in this molecule also provides a site for further derivatization, allowing for the creation of more complex structures with tailored biological activities.

One of the most exciting aspects of working with< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine is its potential as a building block for more sophisticated drug candidates. Researchers have leveraged its structural features to develop molecules that exhibit improved pharmacokinetic properties or enhanced binding affinity to therapeutic targets. This approach aligns with the growing trend in drug discovery towards rational design based on detailed structural analysis and computational modeling.

The synthesis of< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic strategies include nucleophilic substitution reactions at the thiazole ring followed by functional group transformations to introduce the desired substituents. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore this compound further in both academic and industrial settings.

In addition to its pharmaceutical applications, there is growing interest in< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine as a key intermediate in materials science. Thiazole derivatives have been investigated for their potential use in organic electronics, including light-emitting diodes (LEDs) and photovoltaic cells. The electron-deficient nature of the thiazole ring makes it an attractive component for designing materials with specific electronic properties.

The< strong>CAS No. 642929-37-1 designation ensures that researchers can reliably identify and source this compound for their studies. Regulatory agencies and chemical databases rely on such identifiers to maintain consistency in chemical nomenclature and ensure accurate tracking of substances throughout the research and development process. This standardization is critical for collaborative research projects that span multiple institutions or countries.

Ongoing research into< strong>methyl2-(4-methyl-1,3-thiazol-2-yl)ethylamine continues to uncover new possibilities for its application across different fields. By integrating insights from computational chemistry, medicinal chemistry, and materials science, scientists are paving the way for innovative solutions that address complex challenges in medicine and technology. The versatility of this compound underscores its importance as a subject of scientific inquiry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)